Valuation: PERRIGO

Market Cap 1.81B 535B 1.57B 1.47B 1.34B 2.51B 173B 2.56B 17.22B 6.73B 86.56B 6.79B 6.65B 288B P/E 2026 *
1,304x
P/E 2027 * 10.9x
Enterprise Value 4.71B 1,394B 4.08B 3.83B 3.48B 6.54B 450B 6.66B 44.86B 17.54B 225B 17.69B 17.31B 751B EV / Sales 2026 *
1.16x
EV / Sales 2027 * 1.12x
Free-Float
99.6%
Yield 2026 *
8.87%
Yield 2027 * 9.1%
Manager TitleAgeSince
Chief Executive Officer 63 2026-06-06
Director of Finance/CFO 51 2022-05-15
Chief Operating Officer - 2025-06-22
Director TitleAgeSince
Director/Board Member 75 2014-10-31
Director/Board Member 61 2016-11-06
Director/Board Member 70 2017-02-05
Change 5-day change 1-year change 3-year change Capi.($)
-2.25%-0.47%+68.30%+115.90% 1,052B
-0.66%+0.43%+47.39%+50.54% 627B
-0.54%+1.39%+20.69%+63.99% 441B
-1.99%-3.32%+38.71%+35.41% 349B
-1.05%-2.81%+23.07%+35.70% 287B
-2.12%-3.67%-1.14%+5.37% 241B
-0.63%+1.04%+40.05%+56.09% 224B
-1.19%-3.41%-9.57%-52.71% 202B
+0.16%+3.87%+16.89%+73.73% 172B
Average -1.14%+0.43%+27.15%+42.67% 399.46B
Weighted average by Cap. -1.36%+0.32%+39.09%+61.29%

Financials

2026 *2027 *
Net sales 4.06B 1,200B 3.51B 3.3B 3B 5.63B 387B 5.73B 38.63B 15.1B 194B 15.24B 14.91B 647B 4.09B 1,209B 3.54B 3.32B 3.02B 5.67B 390B 5.78B 38.91B 15.21B 196B 15.35B 15.02B 651B
Net income -224M -66.26B -194M -182M -166M -311M -21.38B -316M -2.13B -834M -10.72B -841M -823M -35.7B -56.95M -16.84B -49.25M -46.27M -42.08M -79.01M -5.43B -80.43M -542M -212M -2.72B -214M -209M -9.07B
Net Debt 2.9B 859B 2.51B 2.36B 2.15B 4.03B 277B 4.1B 27.64B 10.81B 139B 10.9B 10.67B 463B 2.78B 823B 2.41B 2.26B 2.06B 3.86B 266B 3.93B 26.49B 10.36B 133B 10.45B 10.22B 443B
Logo PERRIGO
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-